These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30244152)

  • 1. Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Clin Immunol; 2018 Dec; 197():110-117. PubMed ID: 30244152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norovirus GII.4 antibodies in breast milk and serum samples: their role preventing virus-like particles binding to their receptors.
    Khodayar-Pardo P; Martínez-Costa C; Carmona-Vicente N; Buesa J
    Pediatr Infect Dis J; 2014 Jun; 33(6):554-9. PubMed ID: 24830517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viral Immunol; 2016 Jun; 29(5):315-9. PubMed ID: 27135874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
    Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice.
    Malm M; Tamminen K; Blazevic V
    Methods Mol Biol; 2016; 1403():259-68. PubMed ID: 27076135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection.
    Blazevic V; Malm M; Vesikari T
    J Med Virol; 2015 Oct; 87(10):1656-61. PubMed ID: 25946711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.
    Malm M; Uusi-Kerttula H; Vesikari T; Blazevic V
    J Infect Dis; 2014 Dec; 210(11):1755-62. PubMed ID: 24970849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against Lewis antigens inhibit the binding of human norovirus GII.4 virus-like particles to saliva but not to intestinal Caco-2 cells.
    Carmona-Vicente N; Allen DJ; Rodríguez-Díaz J; Iturriza-Gómara M; Buesa J
    Virol J; 2016 May; 13():82. PubMed ID: 27206610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
    Huo Y; Wan X; Ling T; Shen S
    Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine.
    Chen W; Kang T; Yuan R; Shao C; Jing S
    Biotechnol Lett; 2020 Jul; 42(7):1211-1218. PubMed ID: 32088791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
    Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
    Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
    Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of a household norovirus outbreak occurred in Valencia (Spain).
    Carmona-Vicente N; Fernández-Jiménez M; Vila-Vicent S; Rodríguez-Díaz J; Buesa J
    BMC Infect Dis; 2016 Mar; 16():124. PubMed ID: 26968797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice.
    Heinimäki S; Malm M; Vesikari T; Blazevic V
    J Immunol Res; 2018; 2018():3487095. PubMed ID: 29682589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens.
    Higo-Moriguchi K; Shirato H; Someya Y; Kurosawa Y; Takeda N; Taniguchi K
    J Med Virol; 2014 Apr; 86(4):558-67. PubMed ID: 24026909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.
    Malm M; Tamminen K; Lappalainen S; Uusi-Kerttula H; Vesikari T; Blazevic V
    Clin Vaccine Immunol; 2015 Jun; 22(6):656-63. PubMed ID: 25903355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding.
    Sapparapu G; Czakó R; Alvarado G; Shanker S; Prasad BV; Atmar RL; Estes MK; Crowe JE
    PLoS Pathog; 2016 Jun; 12(6):e1005719. PubMed ID: 27355511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
    Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.